Holen Sie sich die Stockscreener-App
12.11
0.33%
0.047
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
Wells Fargo Raises Price Target for Liquidia (LQDA) to $25 | LQD - GuruFocus
Liquidia (LQDA): B of A Securities Lowers Price Target to $23 | LQDA Stock News - GuruFocus
# Raymond James reiterates Strong Buy on Liquidia stock amid competition - Investing.com
Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings - GuruFocus
# Raymond James reiterates Strong Buy on Liquidia stock amid competition By Investing.com - Investing.com UK
Biotech Hits A 'Home Run' And Slams Its Two Key Rivals - Investor's Business Daily
Liquidia (LQDA) Sees Surge in Options Activity Ahead of Earnings | LQDA Stock News - GuruFocus
Treprostinil Saga Continues - JD Supra
Liquidia at Jefferies Conference: Strategic Moves in PAH Market - Investing.com
BTIG Raises Liquidia Price Target Following YUTREPIA Approval - Insider Monkey
Judge Denies UTC Bid To Block Liquidia's Lung Drug - Law360
Liquidia (LQDA) Stock Price Target Raised by Analyst | LQDA Stoc - GuruFocus
Raymond James maintains strong buy on Liquidia stock following court ruling By Investing.com - Investing.com South Africa
BTIG raises Liquidia stock price target following FDA approval By Investing.com - Investing.com South Africa
Raymond James maintains strong buy on Liquidia stock following court ruling - Investing.com India
BTIG raises Liquidia stock price target following FDA approval - Investing.com
Liquidia Beats UTC Bid to Block Launch of Lung Drug Yutrepia - Bloomberg Law News
Liquidia stock rises following YUTREPIA shipment news By Investing.com - Investing.com Canada
Liquidia stock rises following YUTREPIA shipment news - Investing.com
Needham raises Liquidia Technologies stock price target after court ruling By Investing.com - Investing.com South Africa
Needham raises Liquidia Technologies stock price target after court ruling - Investing.com
Liquidia (LQDA) Gets Price Target Boost from Needham | LQDA Stock News - GuruFocus
Liquidia Set to Make First Commercial Shipment of Yutrepia for Pulmonary Hypertension - marketscreener.com
Liquidia starts commercial shipment of FDA-approved YUTREPIA By Investing.com - Investing.com India
Liquidia (LQDA) Begins Commercial Launch of YUTREPIA Following L - GuruFocus
Liquidia (LQDA) Begins Commercial Launch of YUTREPIA Following Legal Victory | LQDA Stock News - GuruFocus
Liquidia starts commercial shipment of FDA-approved YUTREPIA - Investing.com
Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD - The Manila Times
BTIG reaffirms buy rating for Liquidia stock amid legal developments By Investing.com - Investing.com South Africa
Gold Is Bullish, But Be Aware Of Deeper Intraday Pullback; Elliott Wave Intraday Analysis - The Globe and Mail
BTIG reaffirms buy rating for Liquidia stock amid legal developments - Investing.com
Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update - mx.advfn.com
Liquidia Told to Swap Two Defenses Ahead of Trial on UTC Patent - Bloomberg Law News
Liquidia (NASDAQ:LQDA) Given New $23.00 Price Target at Wells Fargo & Company - Defense World
Wells Fargo lifts Liquidia stock price target to $23 from $20 By Investing.com - Investing.com South Africa
H.C. Wainwright lifts Liquidia stock target to $35 on FDA nod By Investing.com - Investing.com South Africa
Liquidia (NASDAQ:LQDA) Given New $35.00 Price Target at HC Wainwright - Defense World
Scotiabank Raises Price Target for Liquidia (LQDA) to $37.00 | LQDA Stock News - GuruFocus
These Analysts Boost Their Forecasts On Liquidia - Benzinga
Scotiabank Increases Price Target for Liquidia (LQDA) After Yutrepia Approval | LQDA Stock News - GuruFocus
Liquidia (LQDA) Sees Target Price Increased by Wells Fargo Analy - GuruFocus
Liquidia (LQDA) Sees Target Price Increased by Wells Fargo Analyst | LQDA Stock News - GuruFocus
Liquidia Technologies stock target raised to $33 at Raymond James - Investing.com
Breaking Down Liquidia: 12 Analysts Share Their ViewsLiquidia (NASDAQ:LQDA) - Benzinga
Liquidia (LQDA) Price Target Raised to $35 by HC Wainwright | LQ - GuruFocus
H.C. Wainwright lifts Liquidia stock target to $35 on FDA nod - Investing.com
Liquidia (LQDA) Target Price Boosted Following FDA Approval | LQ - GuruFocus
Scotiabank raises Liquidia stock target to $37 on Yutrepia™ launch By Investing.com - Investing.com South Africa
Scotiabank raises Liquidia stock target to $37 on Yutrepia™ launch - Investing.com
Liquidia (LQDA) Target Price Boosted Following FDA Approval | LQDA Stock News - GuruFocus
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference - Yahoo Finance
Liquidia (LQDA) Gains FDA Approval, Price Target Raised to $23 | - GuruFocus
Liquidia (LQDA) Gains FDA Approval, Price Target Raised to $23 | LQDA Stock News - GuruFocus
Needham Reiterates Buy Rating on LQDA with a Price Target of $25 - GuruFocus
Wells Fargo lifts Liquidia stock price target to $23 from $20 - Investing.com
Needham Reiterates Buy Rating on LQDA with a Price Target of $25.00 | LQDA Stock News - GuruFocus
Jefferies Boosts Liquidia (LQDA) Price Target After FDA Approval - GuruFocus
BTIG raises Liquidia stock price target to $37, maintains buy - Investing.com
Liquidia (LQDA) Sees Price Target Boost After FDA Approval | LQD - GuruFocus
Liquidia (LQDA) Sees Price Target Boost After FDA Approval | LQDA Stock News - GuruFocus
Jefferies raises Liquidia Technologies stock target to $31 - Investing.com
Jefferies Boosts Liquidia (LQDA) Price Target After FDA Approval | LQDA Stock News - GuruFocus
0.34%
7.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):